Abstract: Provided are novel IFB-a binding molecules of human origin, particularly human-derived anti-IFN-? antibodies as well as IFN-? binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits, and methods for use in diagnosis and therapy are described.

Abstract: The embodiments herein relate to method performed by a measurement device, the method comprising: receiving via higher layer signalling, information on resources or resource sets of one or more radio transmission devices transmitting one or more beam signals associated with said resources or resource sets; performing channel measurements of the one or more beam signals, per spatial filter or receiver beam of the measurement device; storing, over at least one time frame, the channel measurements into measurement groups, where each measurement group corresponds to the channel measurements performed using the same spatial filter of the measurement device; and reporting the measurement groups to a network node or correlating the measurements of each measurement group with reference data for each available time frame individually and reporting the result of the correlation to the network node. The embodiments also relate to a method performed by a network node.

Abstract: The embodiments herein relate to method performed by a measurement device, the method comprising: receiving via higher layer signalling, information on resources or resource sets of one or more radio transmission devices transmitting one or more beam signals associated with said resources or resource sets; performing channel measurements of the one or more beam signals, per spatial filter or receiver beam of the measurement device; storing, over at least one time frame, the channel measurements into measurement groups, where each measurement group corresponds to the channel measurements performed using the same spatial filter of the measurement device; and reporting the measurement groups to a network node or correlating the measurements of each measurement group with reference data for each available time frame individually and reporting the result of the correlation to the network node. The embodiments also relate to a method performed by a network node.

Abstract: Compressor for charging a combustion engine, comprising a compressor housing (1) with a volute (2), a compressor wheel (3) being arranged in the compressor housing (1), the compressor wheel (3) turning about an axis (A) and transporting gas into the volute (2), and an inlet channel (4), at least an end portion of the inlet channel (4) being oriented in the direction of the axis (A) in order to direct gas towards the compressor wheel in the axial direction, wherein an exhaust gas channel (5) terminates into the inlet channel (4) upstream of the compressor wheel (3), and wherein the exhaust gas channel (5) can be shut off by means of a valve (6), wherein a housing (8) of a driving device (7) of the valve (6) is integrally formed with the compressor housing (1).

Abstract: The embodiments herein relate to method performed by a radio network node, a network node, a method performed by a UE, a UE, a method performed by a location server and a location server. The method performed by the network node includes: transmitting at least one signal to other network nodes; detecting signals transmitted from said other network nodes; measuring the signal strength of each received signal; transforming said measured signal strengths into a reference point or into measurement data; and transferring or transmitting the reference point or the measurement data to a location entity or a location node or a location server in the network.

Abstract: Provided are novel IFB-a binding molecules of human origin, particularly human-derived anti-IFN-? antibodies as well as IFN-? binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits, and methods for use in diagnosis and therapy are described.

Abstract: Provided are novel IFB-a binding molecules of human origin, particularly human-derived anti-IFN-? antibodies as well as IFN-? binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits, and methods for use in diagnosis and therapy are described.

Abstract: Compressor for charging a combustion engine, comprising a compressor housing (1) with a volute (2), a compressor wheel (3) being arranged in the compressor housing (1), the compressor wheel (3) turning about an axis (A) and transporting gas into the volute (2), and an inlet channel (4), at least an end portion of the inlet channel (4) being oriented in the direction of the axis (A) in order to direct gas towards the compressor wheel in the axial direction, wherein an exhaust gas channel (5) terminates into the inlet channel (4) upstream of the compressor wheel (3), and wherein the exhaust gas channel (5) can be shut off by means of a valve (6), wherein a housing (8) of a driving device (7) of the valve (6) is integrally formed with the compressor housing (1).

Abstract: Method for controlling the supply of oil to an internal combustion engine, comprising a procedure for detecting a potentially dangerous condition for the correct operation of an internal combustion engine (1). Said condition is the clogging of an oil filter (3) upstream of the engine (1) or the excessive presence of fuel in the lubricant oil. The detection procedure comprises the steps of: changing the flow rate of oil that transits through the filter (3) and that is processed by a pump (2) for lubricating the engine (1); detecting the time that passes between changing the oil flow rate and a detection of a pre-established variation in a parameter connected at least with the pressure downstream of said filter (3), said variation being determined by said change of the flow rate, said filter (3) being placed upstream of the engine (1); comparing said time with pre-established values.

Abstract: Provided are novel IFB-a binding molecules of human origin, particularly human-derived anti-IFN-? antibodies as well as IFN-? binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits, and methods for use in diagnosis and therapy are described.

Abstract: Provided are novel IFB-a binding molecules of human origin, particularly human-derived anti-IFN-? antibodies as well as IFN-? binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits, and methods for use in diagnosis and therapy are described.

Abstract: Described is an apparatus for calibrating a position finding device, having a comparer for comparing a received radio signal pattern to a multitude of reference radio signal patterns, a determiner for determining a signal strength difference, and a determiner for determining a calibration value. The comparer for comparing is configured to select a selection subset from the multitude of reference radio signal patterns by means of a measure of matching between the received radio signal pattern and one reference radio signal pattern, respectively. Determination of the calibration value is based on the signal strength difference, and the determiner for determining the calibration value is further configured to provide the calibration value to the position finding device.

Abstract: Provided are novel interleukin-20 (IL-20) binding molecules of human origin, particularly human-derived anti-human IL-20 antibodies as well as IL-20 binding fragments, derivatives and biotechnological derivatives thereof. In addition, pharmaceutical compositions, kits and methods for use in diagnosis and therapy are described. In addition, a cellular enzyme-linked ligand binding assay is described for isolating antibodies and biotechnological derivatives thereof for pharmaceutical use, in particular recombinant human-derived anti-human cytokine antibodies.

Abstract: Provided are novel IFN-? binding molecules of human origin, particularly human-derived anti-IFN-? antibodies as well as IFN-? binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits and methods for use in diagnosis and therapy are described.

Abstract: In a method for operating a valve, one valve element of the valve being able to be moved from a first position into a second position by activating an electrically actuatable actuator, the actuator is activated at least once in a first time interval, and is thereafter not activated in a second time interval, and a signal characterizing a strike of the valve element at the first position is ascertained at electrical terminals of the actuator. During the process, an activation energy of the actuator is gradually modified, and a threshold value of the activation energy at which the valve element is just able or is just no longer able to lift is ascertained.

Abstract: The invention proposes a fuel delivery device for a fuel injection device of an internal combustion engine, having a delivery pump (10) and having at least one high-pressure pump (16). By means of the delivery pump (10), fuel from a storage container (12) is delivered to the suction side of the high-pressure pump (16), and fuel is delivered into a high-pressure region (18) by the high-pressure pump (16). The delivery pump (10) has an adjustable displacement volume, which means that a variable quantity of fuel can be conveyed at the same rotational speed.

Abstract: A method for monitoring a fuel pressure in a fuel injection system of an internal combustion engine. A setpoint fuel pressure is initially set in the fuel injection system. Next, a first fuel injection and a subsequent second fuel injection are executed at a time interval shorter than a decay time of a pressure wave in the fuel injection system, triggerable by the first fuel injection. In an additional step, a monitored fuel injection quantity, which is injected via the second fuel injection, is ascertained. An action is executed if the monitored fuel injection quantity differs from a setpoint fuel injection quantity, which is predefinable for the setpoint fuel pressure, by more than a limiting value. The invention also relates to a computer program product for executing the method and to a device for monitoring a fuel pressure in a fuel injection system of an internal combustion engine.

Abstract: Described is an apparatus for calibrating a position finding device, having a comparer for comparing a received radio signal pattern to a multitude of reference radio signal patterns, a determiner for determining a signal strength difference, and a determiner for determining a calibration value. The comparer for comparing is configured to select a selection subset from the multitude of reference radio signal patterns by means of a measure of matching between the received radio signal pattern and one reference radio signal pattern, respectively. Determination of the calibration value is based on the signal strength difference, and the determiner for determining the calibration value is further configured to provide the calibration value to the position finding device.

Abstract: Described is an apparatus for calibrating a position finding device, having a comparer for comparing a received radio signal pattern to a multitude of reference radio signal patterns, a determiner for determining a signal strength difference, and a determiner for determining a calibration value. The comparer for comparing is configured to select a selection subset from the multitude of reference radio signal patterns by means of a measure of matching between the received radio signal pattern and one reference radio signal pattern, respectively. Determination of the calibration value is based on the signal strength difference, and the determiner for determining the calibration value is further configured to provide the calibration value to the position finding device.